A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...

The Wall Street Fashion Show describes the shift of hot money from established narratives like AI to new fads. Learn more ...

Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...